Document is current
Any future updates will be listed below
-
Authors
Whelan, Kevin https://orcid.org/0000-0001-5414-2950
Alexander, Margaret
Gaiani, Claire https://orcid.org/0000-0003-0434-8453
Lunken, Genelle
Holmes, Andrew https://orcid.org/0000-0002-7406-4387
Staudacher, Heidi M.
Theis, Stephan
Marco, Maria L. https://orcid.org/0000-0002-3643-9766
- License Information
-
More Information
Article History
Received: 19 November 2023
Accepted: 12 September 2024
First Online: 30 October 2024
Competing interests
: K.W. has received research grants from commercial funders, including the Almond Board of California, Danone and International Nut and Dried Fruit Council, has received speaker fees from Yakult UK and Danone and is the holder of a joint patent to use volatile organic compounds in the diagnosis and dietary management of irritable bowel syndrome (Biomarkers for irritable bowel syndrome, PCT/GB2020/051604). C.G. has received research grants from commercial funders, including Nestlé, Arla Food Ingredients, the French Dairy Interbranch Organization and the International Fine Particle Research Institute, and benefited from the support of the project GEL ANR-18-CE21-0003 of the French National Research Agency. H.M.S. has served as a speaker for the Rome Foundation, Dietitian Connection and Microba, and was a consultant for DSM Pharmaceuticals. S.T. is an employee of Südzucker/BENEO Group. M.L.M. is on the NURA scientific advisory board, ISAPP Board of Directors and Institute for the Advancement of Food and Nutrition Sciences subcommittee on live microorganisms. The other authors declare no competing interests.
